首页> 外文OA文献 >Interim report on the safety and efficacy of longer-term treatment with nusinersen in later-onset spinal muscular atrophy (SMA): Results from the shine study

【2h】

Interim report on the safety and efficacy of longer-term treatment with nusinersen in later-onset spinal muscular atrophy (SMA): Results from the shine study

机译：临时报告在后期发作脊柱肌萎缩中植株长期治疗安全性和疗效的报告（SMA）：亮相研究结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
J. Kirschner; B.T. Darras; M.A. Farrar; E. Mercuri; C.A. Chiriboga; N.L. Kuntz; P.B. Shieh; M. Tulinius; J. Montes; S.P. Reyna; G. Gambino; R. Foster; I. Bhan; J. Wong; W. Farwell;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Interim report on the safety and efficacy of longer-term treatment with nusinersen in later-onset spinal muscular atrophy (SMA): results from the SHINE study [J] . Kirschner J., Darras B., Farrar M., Neuromuscular disorders: NMD . 2019,第Suppla1期

机译：临时报告在后期发病脊柱肌萎缩（SMA）中植株长期治疗的安全性和疗效报告（SMA）：亮相研究结果
2. Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): end of study results from the phase 3 CHERISH study [J] . Mercuri E., Finkel R., Kirschner J., Neuromuscular disorders: NMD . 2017,第Suppla2期

机译：植物血管患儿在患有后发病脊柱肌肉萎缩（SMA）的疗效和安全性：第3期珍惜研究的研究结果
3. Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): end of study results from the phase 3 CHERISH study [J] . Mercuri E., Finkel R., Kirschner J., Neuromuscular disorders: NMD . 2017,第Suppla2期

机译：植物血管患儿在患有后发病脊柱肌肉萎缩（SMA）的疗效和安全性：第3期珍惜研究的研究结果
4. Effects of Electromagnetic Fields in Spinal Muscular Atrophy: A Case Report [C] . L. Canedo, J. Martinez-Mata, G. Serrano-Luna Mexican Symposium on Medical Physics . 2004

机译：电磁场在脊柱肌萎缩中的影响：案例报告
5. Nusinersen Treatment and Healthcare Costs in Spinal Muscular Atrophy [D] . Fox, David A. 2020

机译：血缘肌肉萎缩的螺母治疗和医疗保健成本
6. Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study [O] . Darryl C. De Vivo, Enrico Bertini, Kathryn J. Swoboda, -1

机译：Nusinersen在症状性脊髓性肌萎缩症的症状前期开始于婴儿：2期NURTURE研究的中期疗效和安全性结果
7. Nusinersen in infants who initiate treatment in a presymptomatic stage of spinal muscular atrophy (SMA): Interim results from the phase 2 nurture study [O] . M.M. Ryan, D.C. De Vivo, E. Bertini, 2019

机译：在婴儿在脊髓肌萎缩（SMA）假设阶段的婴儿中的鼻内森：2阶段培养研究的中期结果
8. Columbia SMA Project: A Randomized, Control Trial of the Effects of Exercise on Motor Function and Strength in Patients with Spinal Muscular Atrophy (SMA). [R] . De Vivo, D. C. 2012

机译：哥伦比亚sma项目：运动对脊髓性肌萎缩症（sma）患者运动功能和力量影响的随机对照试验。

Interim report on the safety and efficacy of longer-term treatment with nusinersen in later-onset spinal muscular atrophy (SMA): Results from the shine study

著录项

相似文献

相关主题

期刊订阅